What is it about?

Reiterova et al. presents a standardized approach for T-ALL MRD assessment on day 15 of treatment, which is aplicable in great majority of pediatric cases. Both expert and guided analysis show high level of concordance with local analysis.

Featured Image

Read the Original

This page is a summary of: Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach, Clinical Chemistry and Laboratory Medicine (CCLM), March 2025, De Gruyter,
DOI: 10.1515/cclm-2024-1503.
You can read the full text:

Read

Contributors

Be the first to contribute to this page